This report examines how microbes can be used for the fermentation of cannabinoids, the advantages of biosynthesis over traditional plant extraction, and how biotechnology promises to provide industrial-scale solutions to this fast-growing market. Cannabinoid microbial production has attracted some major industrial players, and the biotech investments build up a significant momentum. For example, Amyris and LAVVAN announced a $300M deal to bring fermentation-derived cannabinoids to the market, Ginkgo Bioworks signed a $100M partnership with Cronos Group, and Intrexon just announced a $100m deal with Surterra to produce cannabinoids with a yeast fermentation platform. Learn more about the emerging cannabinoid fermentation industry at SynBioBeta 2019, October 1-3, San Francisco.Download the report: